Quantification of microenvironmental metabolites in murine cancer models reveals determinants of tumor nutrient availability by Sullivan et al.
Cancer metabolism: what can we learn from analysing metabolites in tumour infiltrating fluid rather than in blood plasma?
Selected by Maria Rafaeva. Read the preLight here
Mechanical Stretch Kills Transformed Cancer Cells by Tijore et al.
Forcefully aiming at cancer cells.
Selected by Vibha Singh. Read the preLight here
A metabolic switch from OXPHOS to glycolysis is essential for cardiomyocyte proliferation in the regenerating heart by Honkoop et al.
Heart regeneration: Cardiomyocytes need to undergo a metabolic switch in order to re-enter the cell cycle.
Selected by Andreas van Impel. Read the preLight here
A schizophrenia risk gene, NRGN, bidirectionally modulates synaptic plasticity via regulating the neuronal phosphoproteome by Hongik Hwang
Hwang et al. show neurogranin regulates CaM-Ca2+ levels and phosphatase activity in the post-synaptic compartment and influences synaptic plasticity.
Selected by Laura McCormick. Read the preLight here
A conserved MFS orchestrates a subset of O-glycosylation to facilitate macrophage dissemination and tissue invasion by Valoskova et al.
Minerva instructs Drosophila embryonic macrophages to push the boundaries of tissue invasion by initiating a developmentally controlled program of glycosylation.
Selected by Giuliana Clemente. Read the preLight here
Applications of Machine Learning in Decision Analysis for Dose Management for Dofetilide by Levy et al.
AND
Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung Cancer
by Schneider et al.
Where dosing dreams are born: Developments in drug toxicity modelling and reinforcement learning in optimising drug dosing regimens.
Selected by Zhang-He Goh. Read the preLight here
Bacteriophage resistance alters antibiotic mediated intestinal expansion of enterococci by Chatterjee et al.
Resistance is futile: Phage therapy used with antibiotics to combat enterococci in a dysbiotic microbiota.
Selected by Yasmin Lau. Read the preLight here
Tracking the popularity and outcomes of all bioRxiv preprints by Abdill & Blekhman
What makes preprints popular? preLighters respond to a meta-analysis of bioRxiv preprints.
Read the preLight here
- © 2019. Published by The Company of Biologists Ltd
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
DMM and COVID-19
We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.
Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.
Do you have an idea for a Workshop?
Our Workshop programme may be on hold for now, but we are welcoming ideas for the 2022 line-up. The proposal deadline is 29 May 2020, so find out how to pitch your idea to the Workshop Committee in good time.
Interviews – Sneh, Mami and Myumi
Continuing our ongoing support to early-career researchers, Sneh Harsh, Mami Uemura and Myumi Higashi share the story behind their latest DMM research, what this means for the field and where their science journey is heading to next.
Membrane trafficking in health and disease
Martin Lowe and his team summarise the major intracellular membrane trafficking pathways and associated molecular machineries, and describe how defects in these give rise to disease in humans, in an At a Glance article and poster.
Editor's choice - Familial hypercholesterolemia class II LDL receptor response to statin treatment
Nolan L Boyd and colleagues used an iPSC-based model of familiar hypercholeserolemia to investigate how mutant LDL receptors respond to statins.